Medical education giant Jumo Health and the I Choose Life Foundation (ICLF) have announced a partnership to expand the range of health equity services to include the recruitment and retention of minority populations for clinical trial eligibility and participation. The Black population comprises only approximately five percent of clinical trial participants in the U.S., notwithstanding the fact that they encompass roughly fourteen percent of the overall U.S. population.
Jumo Health and ICLF have developed a national network of more than 2,000 churches that primarily serve Black congregations, which has more than 500,000 members, to facilitate access to a community that is historically underrepresented in clinical trials.
This move comes after the US Food and Drug Administration (FDA) acknowledged the disparity in clinical trial representation and issued draft guidance that will soon require pharmaceutical companies to create a “Race and Ethnicity Diversity Plan” for each new drug in development.
Jumo Health also announced its creation of a Community Advisory Recruitment and Engagement Solutions Council (the CARES Council) comprised of Black leaders charged with facilitating and advancing its education, outreach and other key health equity efforts.
